Impact of Induction Agent on Treatment and Outcomes in Septic Shock Patients
Author Information
Author(s): Ray David Charles, McKeown Dermot William
Primary Institution: Royal Infirmary of Edinburgh
Hypothesis
Does the choice of induction agent affect the need for vasopressors and steroids, and the outcomes in patients with septic shock?
Conclusion
Etomidate use in critically ill patients should consider various factors beyond adrenal suppression, as it does not significantly impact outcomes or therapy needs.
Supporting Evidence
- Hospital mortality was 65% among the studied patients.
- Etomidate caused less cardiovascular depression compared to other agents.
- Patients given etomidate required vasopressor therapy less frequently.
Takeaway
This study looked at patients with severe infections and found that the type of medicine used to put them to sleep didn't change how many needed extra help with blood pressure or how well they did overall.
Methodology
Retrospective analysis of septic shock patients admitted to an ICU over a 40-month period, reviewing induction agent use and clinical outcomes.
Potential Biases
Potential ascertainment bias due to reliance on database records.
Limitations
The study is retrospective, and some patients may have been misdiagnosed or excluded due to missing data.
Participant Demographics
{"male_female_ratio":"90:69","mean_age":65,"apache_ii_score":28,"predicted_mortality":"69%"}
Statistical Information
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website